Articles from Investor Brand Network

The Maryland state Senate has approved a measure aimed at protecting rescue and fire workers from being penalized for using medical cannabis while off duty. The legislation, introduced by Senator Carl Jackson, passed with a 36-8 vote and now moves to the House of Representatives, where a parallel measure has been introduced but has yet to progress.

The 2025 Prospectors & Developers Association of Canada (“PDAC”) Convention wrapped up in style this March, solidifying its position as one of the world’s premier events for the mining and resource sectors. Held at the Metro Toronto Convention Centre, PDAC 2025 attracted thousands of industry professionals, investors, and innovators from across the globe to discuss the latest trends, opportunities, and challenges facing the mining industry today.

Thumzup (NASDAQ: TZUP), an emerging player in social media branding and programmatic marketing, reported that company insiders acquired approximately $60,381 in common stock during the March 2025 trading window, following $62,000 in purchases in Dec. 2024. Cumulatively, insiders have invested over $740,000 in the company since inception. Thumzup also repurchased about $216,000 worth of stock in the past three trading days under its $1 million buyback program, signaling continued confidence in its growth trajectory. The company recently surpassed 700 advertisers and maintains a CAGR above 200 percent.

ETHDenver 2025 was a major event in the blockchain world, bringing together innovators, developers, and industry leaders to discuss the future of Web3, artificial intelligence (AI), and Decentralized Physical Infrastructure Networks (DePIN). The event was filled with exciting developments, showing how these technologies are growing and shaping real-world applications. Here are the key trends that stood out.

The global golf equipment market is experiencing significant growth, driven by increasing participation and technological advancements. This upward trend presents substantial opportunities for companies operating within the golf-equipment sector, such as Newton Golf Company (NASDAQ: NWTG), a technology-forward golf equipment manufacturer committed to enhancing player performance through innovative design.

Walter Reed National Military Medical Center officials confirmed they are awaiting a $4.9m grant to study MDMA with a focus on troops on active duty. The money will be provided by the U.S. Department of Defense (DOD).

California recently extended a ban on intoxicating hemp products with THC that was set to expire before the end of March. This comes just months after the ban went into effect following legislators’ failure to approve a measure that would’ve regulated these products.

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, reported a full-year 2024 net loss of $39.4 million, or $5.67 per share, compared to a loss of $49.5 million in 2023. Revenue remained limited, but Clene highlighted regulatory progress and survival data supporting CNM-Au8, its gold nanocrystal suspension for ALS. The company expects to meet with the FDA in Q2 2025 to finalize analysis plans for biomarker data, with a potential accelerated NDA submission in the second half of 2025. Clene ended the year with $12.2 million in cash and expects to begin enrollment for its confirmatory Phase 3 RESTORE-ALS trial in mid-2025.

Datavault AI (NASDAQ: DVLT), a leader in AI-powered data valuation and monetization, announced its inclusion in IBM’s Partner Plus program, joining a global network of 500 partners. The company will integrate IBM watsonx tools into its AI agents—Data Vault Bank®, DataScore® and DataValue®—to advance secure, compliant enterprise data monetization. Datavault AI also completed integration with identity partner CLEAR and expanded its strategic alliance with NYIAX. These developments position the company at the forefront of AI-driven financial modeling and tokenization across highly regulated sectors.

There is a growing trend in which parents take tiny doses of psychedelics like LSD and psilocybin in order to cope with the challenges of parenting. Is microdosing psychedelics for these reasons a breakthrough on parenting, or is it simply reckless nonsense?

A proposal introduced by Sen. Colleen Burton that would ban delta-8 THC hemp products is being discussed by legislators in Florida. The measure, SB 438, would also restrict levels of delta-9 THC in hemp products to 50mg per package and 5mg per serving.

Recent data from the U.S. Census Bureau reveals that retail sales have slowed nationwide amid a surge in e-commerce. A preliminary analysis of the latest retail sales figures suggests that consumers are becoming increasingly cautious with their spending, opting to save more wherever possible.

Standard Lithium (NYSE American: SLI), a near-commercial lithium company, reported financial and operational results for the six-month period ended Dec. 31, 2024, highlighting key milestones toward its South West Arkansas project. The company finalized a $225 million grant from the U.S. Department of Energy to support Phase 1 construction and completed successful pilot testing with over 99% lithium recovery. With FEED and DFS nearing completion and offtake discussions underway, Standard Lithium is progressing toward a final investment decision. The company also launched the Smackover Lithium joint venture with Equinor and ended the period with $31.2 million in cash and no debt.

Aditxt (NASDAQ: ADTX) announced that its subsidiary, Pearsanta, Inc., has acquired key patents for adductomics-based DNA damage detection in a $1 million stock transaction. The move expands Pearsanta’s capabilities in early cancer risk assessment, complementing its existing Mitomic® Technology. The acquired technology detects DNA adducts—early markers of carcinogen exposure—allowing for potential cancer prevention strategies before permanent mutations develop. Pearsanta plans to advance clinical validation and regulatory pathways over the next two to three years, aiming to commercialize the diagnostics through CLIA/CAP-certified labs.

Tonix Pharmaceuticals (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a robust development pipeline, announced that the FDA will not require an Advisory Committee meeting to evaluate its New Drug Application for TNX-102 SL, a potential new treatment for fibromyalgia. If approved, TNX-102 SL would be the first new fibromyalgia therapy in 15 years. The drug, which previously received Fast Track designation, could launch in the fourth quarter of 2025. TNX-102 SL targets central sensitization and aims to address widespread dissatisfaction with current treatments.

Brera Holdings (NASDAQ: BREA), an Ireland-based international holding company focused on multi-club ownership, spotlighted the Juve Stabia Academy for its role in developing elite football talent in the Naples Metropolitan Area. The investment reflects Brera’s strategy to support grassroots football and create a global network of academies. Juve Stabia has a history of producing top-tier talent, including Luigi Vitale and Antonio Donnarumma, and aligns with Brera’s mission to strengthen football ecosystems and expand pathways for emerging players worldwide.

HealthLynked (OTCQB: HLYK), a global healthcare network focused on improving patient care, announced updates to its in-office online appointment booking system and enhancements to its ARi voice assistant. New scheduling features include next-available or specific-day requests, flexible time-of-day preferences, and the ability to submit provider reviews without logging in. Upgrades to ARi include improved background noise filtering and smarter response detection, designed to boost reliability and user experience. These innovations aim to streamline scheduling and enhance communication between patients and healthcare providers.

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company, reported fourth quarter and full year 2024 results, highlighting major milestones in its buntanetap program for Alzheimer’s and Parkinson’s disease. The company completed two key trials last year, showing cognitive and motor improvements, leading to FDA clearance for a pivotal Phase 3 trial in early Alzheimer’s, which began in early 2025. Annovis also expanded its patent portfolio, strengthened its leadership, and increased investor engagement. Financially, R&D expenses dropped to $20 million for the year, with net loss per share improving to $2.02 basic from $6.23 in 2023. Cash on hand rose to $10.6 million, with additional funding extending runway into Q4 2025.

A recent study involving more than 1,000 adults suggests that marijuana use may influence changes in the body’s epigenome, which acts like a series of switches turning genes on or off to regulate bodily functions.

Upstream published a blog today that discussed challenges faced by legacy stock exchanges transitioning to 24/5 trading, outlining obstacles such as outdated infrastructure, regulatory hurdles, operational constraints for brokers and clearing firms, liquidity fragmentation, and cybersecurity risks. Significant upgrades are needed for traditional exchanges to support real-time settlement and extended trading hours. On the other hand, blockchain-powered platforms like Upstream are designed to overcome these hurdles. Upstream enables 20/7, peer-to-peer trading, liquidity, a fair trading ecosystem, and biometric authentication and smart contracts to ensure transparency and security. Upstream believes continuous market access is the future and is committed to driving this evolution.

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company at the forefront of research and development of innovative treatments in the field of immuno-oncology. With cancer being the second leading cause of death globally, the company focuses on harnessing antitumor virotherapies and patented technologies designed to protect and potentiate the virotherapy during administration to combat cancer more effectively and with fewer side effects. The company’s approach includes a systemic platform using extracellular enveloped viruses and an intratumoral platform utilizing stem cells to protect the therapy from the body’s immune system during administration. Calidi’s pipeline includes promising therapies such as RTNova, targeting lung and metastatic cancers, SuperNova, targeting solid tumors such as head and neck, triple-negative breast cancer and soft tissue sarcoma, as well as NeuroNova, designed for patients with glioblastoma and other high-grade gliomas. These cutting-edge therapies aim to address critical gaps in current cancer treatments. As the global cancer burden continues to grow, Calidi is poised to play a pivotal role in shaping the future of oncology drug development.

TC BioPharm (NASDAQ: TCBP), a clinical-stage biotech company focused on allogeneic gamma-delta T cell therapies, announced it will be delisted from the Nasdaq Stock Market following a determination by the Nasdaq Hearings Panel. The decision, dated March 20, 2025, stems from the company’s failure to meet the minimum $1.00 bid price required under Rule 5550(a)(2). Trading on Nasdaq will be suspended at the opening on March 24, and the company expects its American Depositary Shares to begin trading on the OTC Markets the same day. TC BioPharm stated it is appealing the decision and affirmed its ongoing commitment to research and development.

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), is actively advancing its lead drug candidate, CNM-Au8®. The company presented its progress at two key investor events this month, including the Q1 Virtual Investor Summit and the 37th Annual Roth Conference. At both events, Clene’s management discussed the latest achievements with CNM-Au8, a gold nanocrystal-based oral suspension that targets mitochondrial dysfunction and promotes neuronal health. The drug has shown promising results in Phase 2 trials, including significant survival benefits and delayed clinical worsening in ALS patients. Clene is now preparing to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) in the second half of 2025, aiming for potential accelerated approval.

Brera Holdings (NASDAQ: BREA), an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership (“MCO”) approach, has reiterated its commitment to advancing women’s soccer.

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today announced its recent accomplishments and financial results for the year ended Dec. 31, 2024. “We remain highly focused on advancing our multiple clinical programs as we work towards achieving a number of important and potentially transformational development milestones, including top-line results in 2026 for our actively enrolling confirmatory Phase 3 placebo-controlled study evaluating HyBryte(TM) (synthetic hypericin) in the treatment of early-stage cutaneous T-cell lymphoma (‘CTCL’),” stated Christopher J. Schaber, PhD, president and chief executive officer of Soligenix. “In the second half of this year, we also anticipate reporting top-line results from our ongoing Phase 2 studies for SGX945 (dusquetide) in Behçet’s disease and SGX302 (synthetic hypericin) in mild-to-moderate psoriasis.”

Social media branding and marketing innovator Thumzup (NASDAQ: TZUP) continues building, helping shareholders after its uplisting to the Nasdaq exchange, announcing recently that board members have approved a stock buyback program of up to $1 million in shares and the company has repurchased $126,507 of its common stock from the open market.

AI-powered dashcams are reshaping the trucking industry, improving road safety and fleet efficiency. However, their widespread use also raises privacy concerns for truck drivers and other road users.

Chinese electric vehicle (EV) manufacturer BYD has unveiled a new charging system that could allow EVs to recharge their batteries in just five minutes. Equipped with an astonishing 1,000 kW of charging power, this platform would be twice as fast as the fastest existing EV charger—the Tesla Supercharger network.

Environmental, Social, and Governance (ESG) strategies can greatly enhance value for private equity funds when implemented effectively. A recent study has found that shares of private equity funds publicly listed on exchanges tend to perform better if the companies had low ESG risk scores, underscoring the financial benefits of strong ESG management.

Late last year, Chinese state media revealed that a ‘supergiant’ gold deposit of very high quality was found in central China. Its estimated worth is approximately $83 billion and it could well be the largest ever gold reserve discovered.

A study by the American Medical Association (AMA) has found that discontinuing marijuana testing in pregnant women has improved racial parity without causing harm to newborns. As more than two dozen states now allow recreational marijuana use for eligible adults, tens of millions of people have easy access to the drug.

Glioblastoma continues to be one of the most challenging cancers to treat as it resists even the latest innovations in immunotherapy. Now, a new study conducted by a team at the Sylvester Comprehensive Cancer Center at the University of Miami suggests that, when a specific protein is suppressed, an antiviral immune response increases the effectiveness of immune checkpoint inhibitors .

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has introduced a novel blockchain architecture that incorporates quantum computing techniques to enhance security and efficiency. The company’s new research paper, Blockchain with Proof of Quantum Work, details how a “proof of quantum” algorithm utilizes quantum computation to generate and validate blockchain hashes.

McEwen Mining (NYSE: MUX) (TSX: MUX) through its founder Rob McEwen, has reaffirmed confidence in Goliath Resources (TSX-V: GOT) (OTCQB: GOTRF) by participating in recent warrant exercises, contributing to the $3.2 million Goliath has received since Jan. 1. McEwen, who holds approximately 3.9% of Goliath’s shares, joins Crescat Capital (~14.4%) in leveraging deep-in-the-money warrants ahead of key expiration dates in 2025. This influx of capital strengthens Goliath’s financial position as it continues to advance its 100%-controlled Golddigger Property in British Columbia’s Golden Triangle, a prolific mining district known for major discoveries. Goliath still holds nearly 6.4 million outstanding warrants representing over $6.3 million in potential near-term funding, with $3.6 million worth expiring by May 16.

As countries worldwide accelerate their transition from fossil fuels to renewable energy, the need for more efficient heating and cooling systems is at an all-time high. Applying circular economy principles to indoor climate control could significantly enhance sustainability efforts while reducing emissions from heating and cooling.

Cryptocurrency exchange-traded funds (ETFs) continued to experience outflows last week, with investors pulling out $1.7 billion, according to CoinShares’ latest report. Over the past five weeks, total outflows have reached $6.4 billion. Despite this trend, data from CryptoQuant indicates that long-term crypto investors are still accumulating Bitcoin (BTC), even as the market faces corrections.

NIO Inc. (NYSE: NIO) has officially introduced its latest electric vehicle, Firefly, marking the company’s third sub-brand. Announced on March 16, 2025, Firefly is designed to redefine urban mobility with a blend of innovative technology, smart functionality, and modern aesthetics. The vehicle is expected to enter the market by April 2025, offering a compact yet efficient option for city drivers.

A recent study from the University of Arizona Health Sciences suggests that terpenes found in the marijuana plant may offer a new way to manage post-surgical and fibromyalgia pain. The study expands on prior research conducted by Comprehensive Center for Pain and Addiction member Dr. John Streicher, who previously explored the pain-relieving properties of terpenes in cases of inflammation and nerve pain caused by chemotherapy.

Thumzup (NASDAQ: TZUP), a growing force in social media branding and programmatic marketing, announced the repurchase of $126,507 of its common stock as part of its previously approved $1 million buyback program. The company views the repurchase as a strategic move to enhance shareholder value and reinforce confidence in its growth trajectory. CEO Robert Steele highlighted the buyback as a demonstration of Thumzup’s commitment to capital efficiency and long-term value creation. The company has also reported surpassing 700 advertisers on its platform, with a compound annual growth rate exceeding 200%.

A recent report has revealed that Chinese automotive giant BYD is considering establishing an electric vehicle (EV) assembly plant in Germany . According to Reuters, the Shenzhen, Guangdong-based company is debating whether to construct a third new energy vehicle (NEV) plant in Europe.

A few weeks ago, the European Commission introduced measures aimed at streamlining and simplifying sustainability reporting for businesses. The measures housed under the Omnibus package address key regulatory frameworks, including the Corporate Sustainability Due Diligence Directive (CSDDD), the Corporate Sustainability Reporting Directive (CSRD), the EU Taxonomy and the Carbon Border Adjustment Mechanism (CBAM).

Rare-earth elements (REEs) have dominated the news lately after the explosive meeting between President Trump and Ukraine’s president Zelenskyy resulted in a minerals deal falling through between the two countries. However, America needs to be more concerned about expected supply shortages of copper .

Apple (NASDAQ: AAPL) has lost a key executive from its health division, as Dr. Ricky Bloomfield, formerly the Clinical and Health Informatics Lead, departs to join Oura as its Chief Medical Officer. Bloomfield played a critical role in shaping Apple’s health strategy, including its push into digital health records and wearable health tracking. His move to Oura, a company specializing in smart rings for health monitoring, signals growing competition in the wearable health-tech space, with some analysts seeing it as a potential shift in consumer interest toward ring-based health tracking over smartwatches.

Cannabis advocates in Ohio are expressing frustration with state lawmakers for pushing legislation to modify the state’s marijuana laws. Since voters approved a measure to legalize recreational cannabis in November 2023, GOP leaders have been working to impose more restrictive policies.

New research that appeared in the journal Oncotarget has opened the door to a new way to approach the treatment of oral ulcers induced by chemotherapy. This debilitating and painful side effect of cancer treatment lowers the quality of life of patients undergoing chemotherapy, but oral mucositis remains an unmet medical need.

Jensen Huang, Nvidia’s CEO, will defend the company’s dominance in the AI chip market amid growing concerns about costs during the upcoming firm’s annual developer conference. As the industry leader in high-performance chips, Nvidia has benefited from the surge in AI demand, but competition and shifting market trends are putting pressure on its position.

Match Group (NASDAQ: MTCH), s confronting a proxy challenge from hedge fund Anson Funds, which plans to nominate directors to the company’s 10-member board. Anson, holding approximately 0.6% of Match Group’s shares as of December, has been advocating for over a year for the parent company of Tinder, Hinge, and OkCupid to reassess capital allocation, reduce costs, and evaluate its MG Asia business. The hedge fund has also expressed concerns about corporate governance and executive turnover, noting that Match Group has had four CEOs in five years.

SKYX Platforms (NASDAQ: SKYX), a smart home platform technology company with a portfolio of over 97 issued and pending patents, will host a corporate update call to present its fourth quarter and full-year 2024 financial results. The conference call is scheduled for Monday, March 24, 2025, at 4:30 p.m. Eastern Time. Participating executives include Founder and Executive Chairman Rani Kohen, President Steve Schmidt, Co-CEO Lenny Sokolow, and CFO Marc Boisseau. The call will provide insights into SKYX’s latest advancements, market position, and financial performance.

Walk-in Dermatology is transforming patient access to dermatological care by combining the convenience of urgent care with the expertise of traditional dermatology. In the latest Bell2Bell podcast, Steven Dresner, CEO of Walk-in Dermatology, discusses the company’s mission to provide same-day, high-quality dermatology services without the long wait times typical of traditional practices. Dresner explains how the model serves patients who need immediate care for conditions like rashes or acne but face delays in scheduling with conventional dermatologists.

Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company, has published a peer-reviewed study highlighting a potential breakthrough in addressing drug resistance to EGFR-targeted therapies for non-small cell lung cancer (NSCLC). The study, published in Drug Resistance Updates, identifies CD105 (endoglin) as a key factor in mediating resistance to osimertinib, a frontline treatment for EGFR-mutant NSCLC. Preclinical models demonstrated that targeting CD105 with ENV105 (carotuximab), a CD105-neutralizing antibody, restored treatment sensitivity, suggesting a novel combination therapy strategy to overcome drug resistance. Kairos Pharma is currently evaluating this approach in clinical trials.

Fifty 1 Labs (OTC: FITY) a holding company in the health, wellness, and biotech sectors, has acquired Genetic Networks LLC, a biotech firm founded by Dr. Gennaro D’Urso, for $10 million in common shares. As part of the deal, Dr. D’Urso has been appointed CEO and Chairman, while Brandon Spikes remains President and Director. Genetic Networks, known for its GeneScape platform, is actively negotiating multi-million dollar contracts with the U.S. Department of Defense to develop biothreat countermeasures. The acquisition enhances FITY’s biotech capabilities, positioning it for rapid growth in personalized medicine, drug repurposing, and biodefense solutions.

Adageis, a healthcare technology company reshaping patient care through flexible AI-centric software solutions for healthcare organizations, is set to exceed its Q1 2025 growth expectations as its AI-powered platform continues to gain traction in the healthcare sector. The company now covers more than 250,000 patient lives, a sharp increase from its previously reported 150,000. This growth highlights a rising demand for technology that helps providers successfully transition from fee-for-service models to value-based care.

The European Union (EU) is becoming increasingly reliant on wind energy as it transitions from fossil fuels to cleaner energy sources. Like solar power, wind energy has taken center stage as one of the primary renewable alternatives to fossil fuels such as oil, coal, and natural gas, thanks to its abundance across the EU.

The crypto industry recently faced intense scrutiny from the SEC but ultimately emerged victorious. Now, key figures in the crypto world are turning their attention to the regulator, pushing back in various ways.

Across the world, more people are choosing Sport Utility Vehicles (SUVs) over smaller cars. This trend continues even though experts and environmental groups warn about the harmful effects of SUVs on the climate. Many believed that the future of transportation would be small, energy-efficient electric vehicles (EVs). However, SUVs remain the top choice for car buyers.

Tonix Pharmaceuticals (NASDAQ: TNXP), a biopharmaceutical company developing innovative vaccines, is advancing TNX-801, a live, minimally replicating recombinant virus vaccine designed to protect against mpox. The company reports that TNX-801 has demonstrated single-dose immunity and superior tolerability compared to 20th-century vaccinia vaccines in animal studies. As a new strain of mpox, Clade I, spreads globally—including recent cases in the U.S.—health officials are seeking more effective prevention methods. Tonix believes TNX-801 aligns with the World Health Organization’s criteria for durable, single-dose vaccines that can be administered without special equipment.

A contentious bipartisan measure aimed at addressing the high potency of cannabis in Colorado was withdrawn by its sponsors during a committee hearing. The measure faced immediate backlash, particularly over proposed regulations on specific edibles and age restrictions.

Adageis was featured in a recent article that discussed the company’s positioning as healthcare shifts toward value-based care, where providers are reimbursed for patient outcomes rather than the number of procedures performed. “While the model promises higher-quality care at lower costs, it also introduces complex reimbursement structures that can be difficult to navigate,” the article reads.

Thumzup (NASDAQ: TZUP) is leveraging its proprietary social media marketing platform, AdTech, which drives influencers to catapult the effectiveness of small-business advertising. Having achieved a growth rate of over 200% CAGR, Thumzup now serves more than 700 clients, with projections to exceed 1,000 by the next financial quarter. As social media marketing continues to grow, Thumzup’s innovative platform allows brands to easily customize campaigns and incentivizes influencer engagement with direct cash rewards, making it a disruptive force in the industry. CEO Robert Steele attributed the company’s growth as a testament to the effectiveness of its model, stating, “Our rapid growth to more than 700 advertisers, up from around 200 this time last year, is confirmation of the effectiveness of our disruptive advertising model.”

The rise of Web3 is revolutionizing how we interact with the internet, shifting from centralized platforms to decentralized systems that prioritize user ownership and transparency. As this new digital landscape evolves, companies are looking for skilled professionals to build, manage, and enhance decentralized applications (DApps), smart contracts, and blockchain ecosystems.

A Florida couple has been accused of using an online dating app to lure, torture, and kill a teenage girl. The couple allegedly used dating app Grindr to lure 16-year-old Miranda Corsette to their home in St. Petersburg for a meetup in late February. After torturing and murdering the girl, the St. Petersburg Police Department says, the couple discarded her dismembered remains in a dumpster.

Authentic Holdings (OTC: AHRO) announced its agreement to acquire Goliath Motion Pictures Entertainment in an $11 million equity-based transaction. The acquisition will bring over 40,000 titles, including award-winning shows and films such as In Living Color, The Cosby Show , and Open Range , under Authentic Holdings’ ownership. The deal is structured as Convertible Preferred Stock, with conversion restrictions for three years to minimize shareholder dilution. Management expects the acquisition to strengthen Maybacks Global Entertainment’s market position, increase advertising revenue, and support expansion into all major U.S. markets. An 8-K will be filed with the SEC upon completion.

Datavault AI (NASDAQ: DVLT) announced that Realtek will showcase a new set-top box software development kit (SDK) featuring WiSA E technology at the Convergence India Expo from March 19-21, 2025. The SDK delivers 5.1 spatial audio without added transmitter hardware costs, offering manufacturers a cost-effective way to enhance home entertainment experiences. Datavault AI’s collaboration with Realtek aligns with India’s push for AI and blockchain integration, positioning its patented Data Vault® and ADIO® solutions for enterprise adoption in government, finance, and smart infrastructure. With India’s AI market projected to reach $17 billion by 2027, Datavault AI sees this partnership as a significant opportunity for expansion and data monetization.

Standard Lithium (NYSE American: SLI) announced the appointment of Karen G. Narwold as an independent director to its board. Narwold brings over 30 years of leadership experience in manufacturing and chemicals, most recently serving as Chief Administrative Officer, General Counsel, and Corporate Secretary at Albemarle Corporation. Her expertise in legal, governance, regulatory, and operational matters is expected to support Standard Lithium’s development of lithium projects in the Smackover formation. Narwold also serves on the board of Ingevity Corporation and chairs its Sustainability & Safety Committee.

Telomir Pharmaceuticals (NASDAQ: TELO) announced preclinical findings showing that its telomere-elongating drug, Telomir-1, reduced tumor size by approximately 50% in a prostate cancer animal model. The study demonstrated that Telomir-1 actively suppresses cancer growth while protecting against chemotherapy-induced toxicity when combined with Paclitaxel. Contrary to concerns that telomere-elongating drugs may promote cancer, Telomir-1 selectively benefited healthy cells while inhibiting tumor development. The company is advancing Telomir-1 toward clinical development for oncology and age-related diseases, aiming to submit an Investigational New Drug (IND) application by the end of 2025.

Oragenics (NYSE American: OGEN) announced the filing of its Annual Report on Form 10-K for the year ended Dec. 31, 2024, with the U.S. Securities and Exchange Commission on March 14, 2025. The company’s audited financial statements received an unqualified audit opinion, though an explanatory paragraph raised concerns about its ability to continue as a going concern. Oragenics remains focused on advancing its pipeline of treatments for concussion and brain-related health conditions while pursuing strategic opportunities to ensure long-term growth. Further details are available in Footnote 1 of the financial statements.

G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) announced that its common shares have been included in several major stock indices, including the NYSE Arca Gold Miners Index (GDX), MVIS Global Junior Gold Miners Index (GDXJ), S&P/TSX Composite Index (GSPTSE), and iShares MSCI Canada ETF (EWC). President and CEO Louis-Pierre Gignac stated that the inclusions reflect the company’s commitment to executing its self-perform approach and advancing its gold projects, including the Tocantinzinho Gold Mine. These index additions are expected to enhance trading liquidity and attract institutional investment. The rebalancing for GDX, GDXJ, and GSPTSE is set for March 21, 2025, while EWC was rebalanced on Feb. 28, 2025.

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), has released new data showing that its lead drug candidate, CNM-Au8, significantly extends survival in patients with ALS. The findings were derived from a cross-regimen post hoc analysis of long-term survival in HEALEY ALS Platform Trial participants ( https://ibn.fm/EgWeb ).

Tonix Pharmaceuticals (NASDAQ: TNXP) announced its fourth-quarter and full-year 2024 financial results, alongside key operational updates. The company highlighted preparations for the potential commercial launch of TNX-102 SL for fibromyalgia in Q4 2025, pending FDA approval with a PDUFA date set for Aug. 15, 2025. Tonix remains debt-free, with cash resources projected to support operations into early 2026. The company also reported progress across its pipeline, including TNX-1500 for kidney transplant rejection, TNX-801 for mpox and smallpox, and TNX-1300 for cocaine intoxication. For Q4 2024, net product revenue reached $2.6 million, while the company reported a net loss of $22.1 million. Full-year 2024 net loss was $130 million, with R&D expenses reduced to $40 million from $86.7 million in 2023 due to pipeline prioritization.

The Idaho State Senate has approved a proposed constitutional amendment that would give the legislature sole authority to legalize cannabis and other drugs. The measure, known as House Joint Memorial 4, will be put to a vote in the November 2026 elections.

Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. “Operating through two key segments, the company’s Specialized BioTherapeutics division is dedicated to oncology and inflammation therapies, while its Public Health Solutions segment advances vaccines and therapeutics targeting biothreats and infectious diseases,” reads a recent article. “With a diversified pipeline, multiple orphan and fast-track designations, and collaborations with government agencies, Soligenix is uniquely positioned for potential regulatory approvals and commercialization.”

Trump Media & Technology Group (NASDAQ: DJT) has experienced a significant downturn, with its stock price plummeting 50% since President Donald Trump’s inauguration. The shares closed at a five-month low of $19.17 last week, reflecting broader market challenges. ​

Microsoft (NASDAQ: MSFT) has launched Office 2024 Home & Business for both Mac and PC, offering users a lifetime license as an alternative to the subscription-based Microsoft 365. This version includes essential applications such as Word, Excel, PowerPoint, Outlook, and OneNote. Notably, the 2024 edition integrates AI features like Word’s Smart Compose, providing intelligent suggestions to enhance productivity.

President Donald Trump’s administration has finally pulled the plug and halted the federal government’s ongoing efforts to adopt electric vehicles. A series of internal memos obtained by Colorado Public Radio and NPR have revealed that the U.S. General Services Administration (GSA) has suspended electric vehicle orders temporarily, ordered the closure of some EV charging stations, and halted the installation of new electric vehicle charging stations.

Iran has gone into overdrive in its efforts to import gold over the past months as it braces for additional hardships under the new Trump administration, which is promising a regime of “ maximum pressure ” for the Iranian government.